Search results
Geneoscopy Nabs FDA Approval for Stool-Based Colorectal Cancer Screening Test
GenomeWeb News· 1 day agoOncology diagnostics firm Geneoscopy said on Tuesday that the US Food and Drug Administration has approved its noninvasive, stool-based colorectal cancer
Tricare Lowers Age for Colon Cancer Screenings to 45
Military.com via Yahoo News· 1 week agoTricare beneficiaries at average risk for colorectal cancer can now receive covered screening exams and lab tests five years sooner, at age 45, following...
It may be safe for some to wait 15 years for repeat colonoscopy, study suggests
NBC News via Yahoo News· 6 days agoNew research suggests average-risk patients may only need to get a colonoscopy for colorectal cancer...
New Day Aims to Enter CRC Screening Market With Combined PCR, Immunoassay Test
GenomeWeb News· 3 days agoWith technologies brought under one roof through a pair of deals last summer, New Day Diagnostics aims to complete within the next two years the development of a blood-based screening
Mackenzie Financial Corp Reduces Holdings in Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 2 weeks agoMackenzie Financial Corp cut its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange ...
Xponance Inc. Sells 668 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 2 weeks agoXponance Inc. decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the ...
Daiwa Securities Group Inc. Acquires 400 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 2 weeks agoDaiwa Securities Group Inc. lifted its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
Analysts Set Exact Sciences Co. (NASDAQ:EXAS) PT at $97.44
ETF DAILY NEWS· 22 hours agoExact Sciences Co. (NASDAQ:EXAS – Get Free Report) has received a consensus rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the stock, MarketBeat.com reports ...
Van ECK Associates Corp Sells 9,078 Shares of Exact Sciences Co. (NASDAQ:EXAS)
ETF DAILY NEWS· 6 days agoVan ECK Associates Corp trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing ...
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by California Public Employees Retirement System
ETF DAILY NEWS· 1 week agoCalifornia Public Employees Retirement System lessened its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.0% in the fourth quarter, according to the company in its ...
